Cargando…

Lifetime prevalence and adherence rate of cervical cancer screening among women living with HIV: a systematic review and meta‐analysis

INTRODUCTION: Women living with HIV (WLWH) are more likely to develop cervical cancer. Screening and available healthcare can effectively reduce its incidence and mortality rates. We aimed to summarize the lifetime prevalence and adherence rate of cervical cancer screening among WLWH across low‐ and...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xiangrong, Zhang, Wanting, Sun, Jingyi, Adeloye, Davies, Jin, Huyi, Rudan, Igor, Song, Peige, Jin, Mingjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226725/
https://www.ncbi.nlm.nih.gov/pubmed/37247380
http://dx.doi.org/10.1002/jia2.26090
_version_ 1785050632701345792
author Gao, Xiangrong
Zhang, Wanting
Sun, Jingyi
Adeloye, Davies
Jin, Huyi
Rudan, Igor
Song, Peige
Jin, Mingjuan
author_facet Gao, Xiangrong
Zhang, Wanting
Sun, Jingyi
Adeloye, Davies
Jin, Huyi
Rudan, Igor
Song, Peige
Jin, Mingjuan
author_sort Gao, Xiangrong
collection PubMed
description INTRODUCTION: Women living with HIV (WLWH) are more likely to develop cervical cancer. Screening and available healthcare can effectively reduce its incidence and mortality rates. We aimed to summarize the lifetime prevalence and adherence rate of cervical cancer screening among WLWH across low‐ and middle‐income countries (LMICs), and high‐income countries (HICs). METHODS: We systematically searched PubMed, Web of Science and Embase for studies published between database inception and 2 September 2022, without language or geographical restrictions. Those reporting the lifetime prevalence and/or adherence rate of cervical cancer screening among WLWH were included. Pooled estimates across LMICs and HICs were obtained using DerSimonian–Laird random‐effects models. When the number of eligible studies was greater than 10, we further conducted stratified analyses by the World Health Organization (WHO) region, setting (rural vs. urban), investigation year, screening method, type of cervical cancer screening programme, age and education level. RESULTS: Among the 63 included articles, 26 provided data on lifetime prevalence, 24 on adherence rate and 13 on both. The pooled lifetime prevalence in LMICs was 30.2% (95% confidence interval [CI]: 21.0–41.3), compared to 92.4% in HICs (95% CI: 89.6–94.6). The pooled adherence rate was 20.1% in LMICs (95% CI: 16.4–24.3) and 59.5% in HICs (95% CI: 51.2–67.2). DISCUSSION: There was a large gap in cervical cancer screening among WLWH between LMICs and HICs. Further analysis found that those in LMICs had higher lifetime prevalence in subgroups with urban settings, with older age and with higher education levels; and those in HICs had higher adherence in subgroups with younger age and with higher education levels. CONCLUSIONS: Cervical cancer screening among WLWH falls considerably short of the WHO's goal. There should be continuous efforts to further increase screening among these women, especially those residing in the rural areas of LMICs and with lower education levels.
format Online
Article
Text
id pubmed-10226725
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-102267252023-05-30 Lifetime prevalence and adherence rate of cervical cancer screening among women living with HIV: a systematic review and meta‐analysis Gao, Xiangrong Zhang, Wanting Sun, Jingyi Adeloye, Davies Jin, Huyi Rudan, Igor Song, Peige Jin, Mingjuan J Int AIDS Soc Reviews INTRODUCTION: Women living with HIV (WLWH) are more likely to develop cervical cancer. Screening and available healthcare can effectively reduce its incidence and mortality rates. We aimed to summarize the lifetime prevalence and adherence rate of cervical cancer screening among WLWH across low‐ and middle‐income countries (LMICs), and high‐income countries (HICs). METHODS: We systematically searched PubMed, Web of Science and Embase for studies published between database inception and 2 September 2022, without language or geographical restrictions. Those reporting the lifetime prevalence and/or adherence rate of cervical cancer screening among WLWH were included. Pooled estimates across LMICs and HICs were obtained using DerSimonian–Laird random‐effects models. When the number of eligible studies was greater than 10, we further conducted stratified analyses by the World Health Organization (WHO) region, setting (rural vs. urban), investigation year, screening method, type of cervical cancer screening programme, age and education level. RESULTS: Among the 63 included articles, 26 provided data on lifetime prevalence, 24 on adherence rate and 13 on both. The pooled lifetime prevalence in LMICs was 30.2% (95% confidence interval [CI]: 21.0–41.3), compared to 92.4% in HICs (95% CI: 89.6–94.6). The pooled adherence rate was 20.1% in LMICs (95% CI: 16.4–24.3) and 59.5% in HICs (95% CI: 51.2–67.2). DISCUSSION: There was a large gap in cervical cancer screening among WLWH between LMICs and HICs. Further analysis found that those in LMICs had higher lifetime prevalence in subgroups with urban settings, with older age and with higher education levels; and those in HICs had higher adherence in subgroups with younger age and with higher education levels. CONCLUSIONS: Cervical cancer screening among WLWH falls considerably short of the WHO's goal. There should be continuous efforts to further increase screening among these women, especially those residing in the rural areas of LMICs and with lower education levels. John Wiley and Sons Inc. 2023-05-29 /pmc/articles/PMC10226725/ /pubmed/37247380 http://dx.doi.org/10.1002/jia2.26090 Text en © 2023 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Gao, Xiangrong
Zhang, Wanting
Sun, Jingyi
Adeloye, Davies
Jin, Huyi
Rudan, Igor
Song, Peige
Jin, Mingjuan
Lifetime prevalence and adherence rate of cervical cancer screening among women living with HIV: a systematic review and meta‐analysis
title Lifetime prevalence and adherence rate of cervical cancer screening among women living with HIV: a systematic review and meta‐analysis
title_full Lifetime prevalence and adherence rate of cervical cancer screening among women living with HIV: a systematic review and meta‐analysis
title_fullStr Lifetime prevalence and adherence rate of cervical cancer screening among women living with HIV: a systematic review and meta‐analysis
title_full_unstemmed Lifetime prevalence and adherence rate of cervical cancer screening among women living with HIV: a systematic review and meta‐analysis
title_short Lifetime prevalence and adherence rate of cervical cancer screening among women living with HIV: a systematic review and meta‐analysis
title_sort lifetime prevalence and adherence rate of cervical cancer screening among women living with hiv: a systematic review and meta‐analysis
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226725/
https://www.ncbi.nlm.nih.gov/pubmed/37247380
http://dx.doi.org/10.1002/jia2.26090
work_keys_str_mv AT gaoxiangrong lifetimeprevalenceandadherencerateofcervicalcancerscreeningamongwomenlivingwithhivasystematicreviewandmetaanalysis
AT zhangwanting lifetimeprevalenceandadherencerateofcervicalcancerscreeningamongwomenlivingwithhivasystematicreviewandmetaanalysis
AT sunjingyi lifetimeprevalenceandadherencerateofcervicalcancerscreeningamongwomenlivingwithhivasystematicreviewandmetaanalysis
AT adeloyedavies lifetimeprevalenceandadherencerateofcervicalcancerscreeningamongwomenlivingwithhivasystematicreviewandmetaanalysis
AT jinhuyi lifetimeprevalenceandadherencerateofcervicalcancerscreeningamongwomenlivingwithhivasystematicreviewandmetaanalysis
AT rudanigor lifetimeprevalenceandadherencerateofcervicalcancerscreeningamongwomenlivingwithhivasystematicreviewandmetaanalysis
AT songpeige lifetimeprevalenceandadherencerateofcervicalcancerscreeningamongwomenlivingwithhivasystematicreviewandmetaanalysis
AT jinmingjuan lifetimeprevalenceandadherencerateofcervicalcancerscreeningamongwomenlivingwithhivasystematicreviewandmetaanalysis